Hypertension is a cardiovascular condition that leads to 8.5 million deaths per year around the world and is linked to a higher risk of stroke and kidney failure. Hypertension is defined by a higher-than-normal force the blood pushes on blood vessel walls in between each heart pump. Acupuncture has been around for thousands of years to control for high blood pressure. WAT Medical Enterprise Inc. is a Canadian company that developed a wrist band (BPRelief) that stimulates acupuncture points to decrease high blood pressure.
This research project aims to study the factors which can influence engagement in physical activity in older adults and how it is linked to health. Using data from multiple countries and collected over periods of up to 12 years the research project will look at the influence of socioeconomic and environmental factors on this relationship. The research project will also investigate the individual neuro-psychological factors that influence individuals’ engagement in physical activity with the aim of developing clinical interventions that can increase people’s level of physical activity.
The overall goal of the project is to develop tools to correct people’s running movements using smart garments. The research method will employ an experimental testbed composed of a way to sense gait, a way to change the gait, and a computer program to provide the correction for non-optimal running patterns. The testbed data results will be translated to prototype garments in collaboration with our partner to design athletic wear composed of smart materials g.
Older adults living with frailty recover less quickly following minor illnesses and are more likely to be hospitalized or die. Therefore, it is of importance to identify strategies to prevent or treat frailty. In Canada, there is currently no available multi-component interventions addressing frailty in long-term care settings. This project will evaluate the effectiveness of a multi-component intervention on frailty in Canadian older adults with high risk of frailty in a long-term care home, and explore the feasibility for the planning of future studies with larger group of participants.
The Canadian Nutrition Society is Canada’s leading society for nutrition professionals. As a Fellow, I will work with the Canadian Malnutrition Taskforce—CNS’ flagship initiative—to support integration of a new malnutrition care standard in Canadian hospitals. Advancing Malnutrition Care (AMC) was designed to bring best practices from this standard to hospitals across the country. The aim of my project is to lead the spreading and scaling of the AMC program with focus on capacity-building within the Canadian health system.
Transportation problems are one of the most common barriers, after health problems, that prevent older Canadians from participating in more social, recreational, or group activities. United Way Healthy Aging is working closely with the community-based seniors’ services sector to bring solutions to seniors’ transportation. Through the Better at Home program, United Way Healthy Aging supports a network of over 80 agencies across the province to deliver seniors’ transportation services, typically in the form of seniors’ shuttles, buses, and volunteer driver programs.
This project will look at if and how transcranial magnetic stimulation can be used to influence or delay either observed or perceived muscle fatigue in either continuous or non continuous exhaustive physical activity. The project also will conclude whether or not it would make financial senes, based on observed performance gains, to include transcranial magnetic stimulation devices to pair with with any future brain-machine-interfaces that are developed.
ParticipACTION is Canada’s leading physical activity promotion brand with a mission to support all Canadians to be more active. The goal of this research is to enhance the organization’s physical activity promotion practices for individuals who experience health inequities by identifying inclusive physical activity promotion strategies that currently exist, evaluating perceptions of ParticipACTION as a brand, and developing standards that can be used within physical activity promotion organizations to improve their inclusion and accessibility.
This project looks to examine the safety of the medication Pimavanserin, marketed under the brand name Nuplazid. Pimavanserin is prescribed to manage Parkinson’s Disease Psychosis, a common side effect of Parkinson Disease medications. This medication has already received regulatory approval in the United Stated by the Food and Drug Administration under a special program called the “Breakthrough therapy program”. Although it initially showed promising results, concerns have been raised regarding its safety and efficacy.